Interestingly, this ability to quantify apoptosis has helped us to identify the early low-dose hypersensitivity (LDHS) and low-dose apoptosis (LDA) of most normal tissues but also tumor tissues with intact TP53 and ATM genes [2]. This evidence concerns the gene TP53 and neoplasm.